176 related articles for article (PubMed ID: 11273212)
1. Premature atherosclerosis in HIV-infected individuals--focus on protease inhibitor therapy.
Depairon M; Chessex S; Sudre P; Rodondi N; Doser N; Chave JP; Riesen W; Nicod P; Darioli R; Telenti A; Mooser V;
AIDS; 2001 Feb; 15(3):329-34. PubMed ID: 11273212
[TBL] [Abstract][Full Text] [Related]
2. Carotid artery intima-media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure.
Currier JS; Kendall MA; Zackin R; Henry WK; Alston-Smith B; Torriani FJ; Schouten J; Mickelberg K; Li Y; Hodis HN;
AIDS; 2005 Jun; 19(9):927-33. PubMed ID: 15905673
[TBL] [Abstract][Full Text] [Related]
3. High-density lipoprotein subfractions as markers of early atherosclerosis. PCVMETRA Group. Prévention Cardio-Vasculaire en Medecene du Travail.
Atger V; Giral P; Simon A; Cambillau M; Levenson J; Gariepy J; Megnien JL; Moatti N
Am J Cardiol; 1995 Jan; 75(2):127-31. PubMed ID: 7810486
[TBL] [Abstract][Full Text] [Related]
4. Assessment of atherosclerosis using carotid ultrasonography in a cohort of HIV-positive patients treated with protease inhibitors.
Seminari E; Pan A; Voltini G; Carnevale G; Maserati R; Minoli L; Meneghetti G; Tinelli C; Testa S
Atherosclerosis; 2002 Jun; 162(2):433-8. PubMed ID: 11996964
[TBL] [Abstract][Full Text] [Related]
5. Frequency of Subclinical Atherosclerosis in Brazilian HIV-Infected Patients.
Salmazo PS; Bazan SGZ; Shiraishi FG; Bazan R; Okoshi K; Hueb JC
Arq Bras Cardiol; 2018 May; 110(5):402-410. PubMed ID: 29641646
[TBL] [Abstract][Full Text] [Related]
6. Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors.
Levenson J; Giral P; Razavian M; Gariepy J; Simon A
Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1263-8. PubMed ID: 7670937
[TBL] [Abstract][Full Text] [Related]
7. Impact of protease inhibitor substitution with efavirenz in HIV-infected children: results of the First Pediatric Switch Study.
McComsey G; Bhumbra N; Ma JF; Rathore M; Alvarez A;
Pediatrics; 2003 Mar; 111(3):e275-81. PubMed ID: 12612284
[TBL] [Abstract][Full Text] [Related]
8. Plasma Low-Density Lipoprotein Cholesterol/High-Density Lipoprotein Cholesterol Concentration Ratio and Early Marker of Carotid Artery Atherosclerosis.
Nimkuntod P; Tongdee P
J Med Assoc Thai; 2015 May; 98 Suppl 4():S58-63. PubMed ID: 26201135
[TBL] [Abstract][Full Text] [Related]
9. Progression of carotid artery intima-media thickening in HIV-infected and uninfected adults.
Currier JS; Kendall MA; Henry WK; Alston-Smith B; Torriani FJ; Tebas P; Li Y; Hodis HN
AIDS; 2007 May; 21(9):1137-45. PubMed ID: 17502724
[TBL] [Abstract][Full Text] [Related]
10. Echolucency of the carotid artery intima-media complex and intima-media thickness have different cardiovascular risk factor relationships: the Women's Interagency HIV Study.
Jung M; Parrinello CM; Xue X; Mack WJ; Anastos K; Lazar JM; Selzer RH; Shircore AM; Plankey M; Tien P; Cohen M; Gange SJ; Hodis HN; Kaplan RC
J Am Heart Assoc; 2015 Feb; 4(2):. PubMed ID: 25699995
[TBL] [Abstract][Full Text] [Related]
11. Premature lesions of the carotid vessels in HIV-1-infected patients treated with protease inhibitors.
Maggi P; Serio G; Epifani G; Fiorentino G; Saracino A; Fico C; Perilli F; Lillo A; Ferraro S; Gargiulo M; Chirianni A; Angarano G; Regina G; Pastore G
AIDS; 2000 Nov; 14(16):F123-8. PubMed ID: 11101050
[TBL] [Abstract][Full Text] [Related]
12. Carotid plaque, aging, and risk factors. A study of 457 subjects.
Fabris F; Zanocchi M; Bo M; Fonte G; Poli L; Bergoglio I; Ferrario E; Pernigotti L
Stroke; 1994 Jun; 25(6):1133-40. PubMed ID: 8202970
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and determinants of carotid atherosclerosis in healthy postmenopausal women.
Lassila HC; Tyrrell KS; Matthews KA; Wolfson SK; Kuller LH
Stroke; 1997 Mar; 28(3):513-7. PubMed ID: 9056604
[TBL] [Abstract][Full Text] [Related]
14. Subclinical carotid atherosclerosis and cardiovascular risk factors in HIV-infected patients.
Kwiatkowska W; Knysz B; Drelichowska-Durawa J; Czarnecki M; Gąsiorowski J; Biłyk E; Karczewski M; Witkiewicz W
Postepy Hig Med Dosw (Online); 2011 Nov; 65():770-83. PubMed ID: 22173442
[TBL] [Abstract][Full Text] [Related]
15. Surrogate markers for atherosclerosis in overweight subjects with atherogenic dyslipidemia: the GEMS project.
Genoud M; Wietlisbach V; Feihl F; Mermod A; Morin D; Darioli R; Nicod P; Mooser V; Waeber B; Hayoz D; Waeber G
Angiology; 2008; 59(4):484-92. PubMed ID: 18388087
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of carotid atherosclerosis and serum cholesterol levels in eastern Finland.
Salonen R; Seppänen K; Rauramaa R; Salonen JT
Arteriosclerosis; 1988; 8(6):788-92. PubMed ID: 3196222
[TBL] [Abstract][Full Text] [Related]
17. Intermediate-density lipoproteins and progression of carotid arterial wall intima-media thickness.
Hodis HN; Mack WJ; Dunn M; Liu C; Liu C; Selzer RH; Krauss RM
Circulation; 1997 Apr; 95(8):2022-6. PubMed ID: 9133510
[TBL] [Abstract][Full Text] [Related]
18. Carotid atherosclerosis in renal transplant recipients: relationships with cardiovascular risk factors and plasma lipoproteins.
Barbagallo CM; Pinto A; Gallo S; Parrinello G; Caputo F; Sparacino V; Cefalù AB; Novo S; Licata G; Notarbartolo A; Averna MR
Transplantation; 1999 Feb; 67(3):366-71. PubMed ID: 10030280
[TBL] [Abstract][Full Text] [Related]
19. Impact of cocaine use on protease inhibitor-associated dyslipidemia in HIV-infected adults.
Li J; Lai H; Chen S; Lai S
Int J STD AIDS; 2018 Jul; 29(8):781-789. PubMed ID: 29471762
[TBL] [Abstract][Full Text] [Related]
20. Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction.
Stein JH; Klein MA; Bellehumeur JL; McBride PE; Wiebe DA; Otvos JD; Sosman JM
Circulation; 2001 Jul; 104(3):257-62. PubMed ID: 11457741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
